Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Seven Fleet Capital Management LP reported a 0.50% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Seven Fleet Capital Management LP reported a 0.50% stake in Cytomx Therapeutics, Inc., 1,085,398 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 0.50%
- Shares
- 1,085,398
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Seven Fleet Master Fund LP | 0.50% | 1,085,398 |
| Seven Fleet Capital Management LP | 0.50% | 1,085,398 |
| Seven Fleet Capital Management GP LLC | 0.50% | 1,085,398 |
| Brian Liu | 0.50% | 1,085,398 |
Source
Related
- Cytomx Therapeutics, Inc.
- Seven Fleet Capital Management LP
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · Seven Fleet Capital Management LP · Nov 14, 2025
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026